Trial Profile
A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2011
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions
- 09 Dec 2011 New trial record